[go: up one dir, main page]

DK3890828T3 - Heteroaromatiske forbindelser som vanin-hæmmere - Google Patents

Heteroaromatiske forbindelser som vanin-hæmmere Download PDF

Info

Publication number
DK3890828T3
DK3890828T3 DK19813499.1T DK19813499T DK3890828T3 DK 3890828 T3 DK3890828 T3 DK 3890828T3 DK 19813499 T DK19813499 T DK 19813499T DK 3890828 T3 DK3890828 T3 DK 3890828T3
Authority
DK
Denmark
Prior art keywords
vanine
inhibitors
heteroaromatic compounds
heteroaromatic
compounds
Prior art date
Application number
DK19813499.1T
Other languages
English (en)
Inventor
Cédrickx Godbout
Martin Thomas Fleck
Hannes Fiepko Koolman
Jr Thomas Martin Kirrane
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Application granted granted Critical
Publication of DK3890828T3 publication Critical patent/DK3890828T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10Spiro-condensed systems
    • C07D491/107Spiro-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK19813499.1T 2018-12-03 2019-12-02 Heteroaromatiske forbindelser som vanin-hæmmere DK3890828T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862774412P 2018-12-03 2018-12-03
PCT/EP2019/083259 WO2020114947A1 (en) 2018-12-03 2019-12-02 Heteroaromatic compounds as vanin inhibitors

Publications (1)

Publication Number Publication Date
DK3890828T3 true DK3890828T3 (da) 2025-05-05

Family

ID=68766765

Family Applications (1)

Application Number Title Priority Date Filing Date
DK19813499.1T DK3890828T3 (da) 2018-12-03 2019-12-02 Heteroaromatiske forbindelser som vanin-hæmmere

Country Status (15)

Country Link
US (1) US12240828B2 (da)
EP (1) EP3890828B1 (da)
JP (1) JP7195436B2 (da)
KR (1) KR20210099093A (da)
CN (1) CN113226462B (da)
AU (1) AU2019392524B2 (da)
BR (1) BR112021010823A2 (da)
CA (1) CA3120037A1 (da)
DK (1) DK3890828T3 (da)
EA (1) EA202191478A1 (da)
ES (1) ES3026660T3 (da)
HU (1) HUE070992T2 (da)
MX (1) MX2021006489A (da)
PL (1) PL3890828T3 (da)
WO (1) WO2020114947A1 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL283397B2 (en) * 2018-12-03 2025-03-01 Boehringer Ingelheim Int Heteroaromatic compounds as vanin inhibitors
WO2020123426A1 (en) * 2018-12-11 2020-06-18 F. Hoffmann-La Roche Ag Aminoazine amides
IL301556A (en) * 2020-09-25 2023-05-01 Shanghai Meiyue Biotech Dev Co Ltd Pyrimidine carboxamide compound and its use
TWI811901B (zh) * 2020-12-17 2023-08-11 大陸商上海美悅生物科技發展有限公司 一種嘧啶甲醯胺類化合物及其應用
US20250197414A1 (en) * 2022-03-18 2025-06-19 Shanghai Meiyue Biotech Development Co., Ltd. Salt form and crystal form of vanin enzyme inhibitor, method for preparing same, and use thereof
CN116903592B (zh) * 2023-07-13 2025-08-01 特科罗生物科技(成都)有限公司 一种嘧啶胺类nuak抑制剂及其制备方法和用途

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030195192A1 (en) 2002-04-05 2003-10-16 Fortuna Haviv Nicotinamides having antiangiogenic activity
DE602004018811D1 (de) 2003-10-09 2009-02-12 Abbott Lab Pyrrolidinylharnstoffderivate als angiogeneseinhibitoren
CN103087050A (zh) * 2011-10-28 2013-05-08 山东轩竹医药科技有限公司 芳基激酶抑制剂
US9585891B2 (en) 2012-09-25 2017-03-07 Merck Patent Gmbh Alpha hydroxy amides
US9221807B2 (en) * 2014-02-21 2015-12-29 Boehringer Ingelheim International Gmbh Substituted pyridones and pyrazinones and their use as inhibitors of neutrophil elastase activity
JP2018516254A (ja) * 2015-05-29 2018-06-21 ファイザー・インク バニン1酵素の阻害薬としての新規なヘテロ環化合物
JP6976947B2 (ja) * 2015-12-16 2021-12-08 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 自己免疫疾患の処置に有用なビピラゾリル誘導体
EP3484876A1 (en) * 2016-07-14 2019-05-22 Pfizer Inc Novel pyrimidine carboxamides as inhibitors of vanin-1 enzyme
AU2018285131B2 (en) 2017-06-12 2021-11-11 Boehringer Ingelheim International Gmbh Heteroaromatic compounds as Vanin inhibitors
AU2019326933B2 (en) 2018-08-28 2024-12-05 Boehringer Ingelheim International Gmbh Heteroaromatic compounds as Vanin inhibitors
IL283397B2 (en) * 2018-12-03 2025-03-01 Boehringer Ingelheim Int Heteroaromatic compounds as vanin inhibitors

Also Published As

Publication number Publication date
KR20210099093A (ko) 2021-08-11
JP2022510351A (ja) 2022-01-26
HUE070992T2 (hu) 2025-07-28
BR112021010823A2 (pt) 2021-08-24
PL3890828T3 (pl) 2025-06-16
CA3120037A1 (en) 2020-06-11
CN113226462A (zh) 2021-08-06
AU2019392524B2 (en) 2025-05-08
ES3026660T3 (en) 2025-06-11
US20220048889A1 (en) 2022-02-17
EP3890828B1 (en) 2025-02-19
JP7195436B2 (ja) 2022-12-23
MX2021006489A (es) 2021-07-06
EP3890828A1 (en) 2021-10-13
US12240828B2 (en) 2025-03-04
AU2019392524A1 (en) 2021-07-15
EA202191478A1 (ru) 2021-10-26
CN113226462B (zh) 2025-02-11
WO2020114947A1 (en) 2020-06-11

Similar Documents

Publication Publication Date Title
DK3873903T3 (da) Substituerede 6-azabenzimidazolforbindelser som hpk1-hæmmere
IL292753A (en) Compounds
DK4219492T3 (da) Heterocykliske forbindelser som immunmodulatorer
DK4212529T3 (da) Heterocykliske forbindelser som immunmodulatorer
DK3684767T3 (da) Heterocykliske forbindelser som pad-inhibitorer
DK3697785T3 (da) Imidazo-pyridine forbindelser som pad-inhibitorer
DK3442980T3 (da) Heterocykliske forbindelser som ret-kinase-hæmmere
DK3704120T3 (da) Heterocykliske forbindelser som prmt5-inhibitorer
DK3656769T3 (da) Aryl-phosphor-oxygen-forbindelse som egfr-kinase-inhibitor
DK3788040T3 (da) Pyridazinoner som parp7-inhibitorer
EP3843714C0 (en) CD73 INHIBITORS
DK3768674T3 (da) Aminopyrimidinderivater som ctps1-hæmmere
DK3728252T3 (da) 4-azaindolforbindelser
DK3371190T3 (da) Heterocykliske forbindelser som pi3k-gamma-inhibitorer
LT3810602T (lt) Junginiai
DK3472167T3 (da) Heterocykliske forbindelser som immunomodulatorer
IL304348A (en) Cd73 inhibitors
DK3277677T3 (da) 1-cyano-pyrrolidinforbindelser som usp30-hæmmere
DK3762368T3 (da) Aminopyrazindiolforbindelser som pi3k-y-inhibitorer
DK3609898T3 (da) Forbindelser, der er nyttige som ret-hæmmere
DK3582780T3 (da) Aminopyrimidinforbindelser, der er anvendelige som SSAO-inhibitorer
DK3533796T3 (da) Aminopyrazolopyrimidinforbindelse anvendt som neutrof faktor tyrosinkinasereceptor inhibitor
DK3638680T3 (da) Heteroaromatiske forbindelser som vanininhibitorer
DK3890828T3 (da) Heteroaromatiske forbindelser som vanin-hæmmere
DK3544981T3 (da) Benzodiazoliumforbindelser som enac-inhibitorer